首页> 外文OA文献 >Weighted Likelihood Method for Grouped Survival Data in Case–Cohort Studies with Application to HIV Vaccine Trials
【2h】

Weighted Likelihood Method for Grouped Survival Data in Case–Cohort Studies with Application to HIV Vaccine Trials

机译:应用于HIV疫苗试验的病例队列研究中分组生存数据的加权似然方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Grouped failure time data arise often in HIV studies. In a recent preventive HIV vaccine efficacy trial, immune responses generated by the vaccine were measured from a case–cohort sample of vaccine recipients, who were subsequently evaluated for the study endpoint of HIV infection at prespecified follow-up visits. Gilbert et al. (2005, Journal of Infectious Diseases   191 , 666–677) and Forthal et al. (2007, Journal of Immunology   178, 6596–6603) analyzed the association between the immune responses and HIV incidence with a Cox proportional hazards model, treating the HIV infection diagnosis time as a right-censored random variable. The data, however, are of the form of grouped failure time data with case–cohort covariate sampling, and we propose an inverse selection probability-weighted likelihood method for fitting the Cox model to these data. The method allows covariates to be time dependent, and uses multiple imputation to accommodate covariate data that are missing at random. We establish asymptotic properties of the proposed estimators, and present simulation results showing their good finite sample performance. We apply the method to the HIV vaccine trial data, showing that higher antibody levels are associated with a lower hazard of HIV infection.
机译:分组的故障时间数据经常出现在HIV研究中。在最近的一项预防性HIV疫苗功效试验中,从病例接受者样本中测量了疫苗产生的免疫反应,随后在预先指定的随访中对他们进行了HIV感染的研究终点评估。吉尔伯特等。 (2005年,传染病杂志191,666-677)和Forthal等。 (2007,Journal of Immunology 178,6596–6603)使用Cox比例风险模型分析了免疫反应与HIV发生率之间的关联,将HIV感染的诊断时间视为右删失的随机变量。但是,这些数据是具有案例-队列协变量采样的分组故障时间数据的形式,我们提出了一种逆选择概率加权似然方法,以将Cox模型拟合到这些数据。该方法允许协变量与时间相关,并使用多重插补来适应随机丢失的协变量数据。我们建立了所提出估计量的渐近性质,并给出了模拟结果,显示了它们的良好有限样本性能。我们将该方法应用于HIV疫苗试验数据,表明较高的抗体水平与较低的HIV感染风险相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号